XBIO
XENETIC BIOSCS (XBIO)
NASDAQ
$3.31-$0.07 (-2.22%)
Price as of Jun 03, 2026 4:25 PM EDT
  • $7.2M
    Market Cap
  • 9.05%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.0M
+19.04%
2.5M
-1.56%
2.5M
+48.80%
1.7M
+47.06%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
3.0M
+19.04%
2.5M
-1.56%
2.5M
+48.80%
1.7M
+47.06%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.8M
-45.26%
-3.3M
-5.91%
-3.5M
-26.75%
-4.8M
+50.81%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Operating Expenses
5.8M
-13.33%
6.7M
-4.97%
7.1M
-16.25%
8.4M
+21.97%
Operating Profit
-2.8M
-32.58%
-4.2M
-6.89%
-4.5M
-32.78%
-6.7M
+16.90%
Interest Income
N/A
N/A
65,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
-100.00%
65,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
153,722
-37.04%
244,153
-35.94%
381,137
+130.22%
165,555
+62.97%
Income before Taxes
-2.8M
-32.58%
-4.2M
-6.89%
-4.5M
-32.78%
-6.7M
+16.90%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
700,000
0.00%
700,000
N/A
0
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-4.1M
-36.90%
-6.6M
+16.07%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-4.1M
-36.90%
-6.6M
+16.07%
Basic EPS and Net Income
-1.58
-38.52%
-2.57
-5.17%
-2.71
+489.13%
-0.46
-16.36%
Diluted EPS and Net Income
-1.58
-38.52%
-2.57
-5.17%
-2.71
+489.13%
-0.46
-16.36%
Basic Weighted Average Shares
1.7M
+10.40%
1.5M
+0.86%
1.5M
-89.26%
14.2M
+38.38%
Diluted Weighted Average Shares
1.7M
+10.40%
1.5M
+0.86%
1.5M
-89.26%
14.2M
+38.38%
Balance Sheet
Cash and Cash Equivalents
7.9M
+27.87%
6.2M
-31.36%
9.0M
-31.41%
13.1M
-28.21%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.9M
+27.87%
6.2M
-31.36%
9.0M
-31.41%
13.1M
-28.21%
Total Current Assets
8.0M
+22.20%
6.6M
-31.29%
9.6M
-29.78%
13.7M
-27.08%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Long-Term Assets
313,921
0.00%
313,921
-69.17%
1.0M
-4.55%
1.1M
-2.29%
Total Assets
8.4M
+21.19%
6.9M
-34.92%
10.6M
-27.96%
14.7M
-25.71%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
968,025
+8.25%
894,263
+10.46%
809,585
-24.56%
1.1M
-24.48%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
968,025
+8.25%
894,263
+10.46%
809,585
-24.56%
1.1M
-24.48%
Retained Earnings
-199.9M
+1.36%
-197.2M
+2.05%
-193.2M
+2.19%
-189.1M
+3.59%
Total Stockholders Equity
7.4M
+23.12%
6.0M
-38.67%
9.8M
-28.22%
13.6M
-25.81%
Total Shares Outstanding
2.3M
+48.56%
1.5M
+0.09%
1.5M
-89.84%
15.2M
+12.85%
Cash Flow
Cash from Operating Activities
-2.3M
-18.84%
-2.8M
-31.52%
-4.1M
-11.46%
-4.6M
-1.93%
Capital Expenditures
N/A
N/A
N/A
N/A
500,000
0.00%
500,000
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
0
+100.00%
-500,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.0M
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-95.23%
-43.37%
-168.16%
-5.41%
-177.78%
-54.83%
-393.57%
-20.51%
Return on Assets
N/A
N/A
N/A
N/A
-32.65%
-13.95%
-37.95%
+10.89%
Return on Equity
N/A
N/A
N/A
N/A
-35.27%
-13.75%
-40.90%
+10.88%
Revenue Growth
19.04%
+1,318.28%
-1.56%
-103.20%
48.80%
+3.71%
47.06%
-71.59%
Current Ratio
8.32
+12.89%
7.37
-37.79%
11.84
-6.92%
12.72
-3.44%
Cash Ratio
8.14
+18.12%
6.89
-37.86%
11.10
-9.08%
12.20
-4.93%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow